Prudential Financial Inc Iovance Biotherapeutics, Inc. Transaction History

Prudential Financial Inc

$70 Billion
Q3 2024

A detailed history of Prudential Financial Inc transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 17,248 shares of IOVA stock, worth $140,398. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,248

Previous 71,410 75.85%

Holding current value

$140,398

Previous $572,000 71.85%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$7.28 - $11.9 $394,299 - $644,527	-54,162 Reduced 75.85%	17,248 $161,000
Q2 2024 Aug 13, 2024	SELL	$7.78 - $14.19 $32,310 - $58,931	-4,153 Reduced 5.5%	71,410 $572,000
Q1 2024 May 14, 2024	BUY	$7.59 - $17.47 $460,470 - $1.06 Million	60,668 Added 407.3%	75,563 $1.12 Million
Q4 2023 Feb 13, 2024	BUY	$3.3 - $8.89 $2,323 - $6,258	704 Added 4.96%	14,895 $121,000
Q3 2023 Nov 13, 2023	BUY	$4.44 - $8.79 $4,324 - $8,561	974 Added 7.37%	14,191 $64,000
Q2 2023 Aug 11, 2023	BUY	$5.36 - $9.06 $15,576 - $26,328	2,906 Added 28.18%	13,217 $93,000
Q1 2023 May 12, 2023	SELL	$5.53 - $8.22 $1,365 - $2,030	-247 Reduced 2.34%	10,311 $63,000
Q4 2022 Feb 14, 2023	BUY	$5.62 - $10.0 $1,202 - $2,140	214 Added 2.07%	10,558 $0
Q3 2022 Nov 04, 2022	SELL	$9.53 - $13.11 $9,711 - $13,359	-1,019 Reduced 8.97%	10,344 $99,000
Q2 2022 Aug 15, 2022	BUY	$6.38 - $18.33 $72,495 - $208,283	11,363 New	11,363 $123,000
Q1 2021 May 12, 2021	SELL	$28.67 - $52.59 $1.15 Million - $2.1 Million	-39,945 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$28.04 - $50.26 $1.12 Million - $2.01 Million	39,945 New	39,945 $1.85 Million
Q2 2020 Aug 12, 2020	SELL	$27.21 - $41.0 $6,095 - $9,184	-224 Closed	0 $0
Q1 2020 Aug 05, 2021	SELL	$19.54 - $38.85 $141,977 - $282,284	-7,266 Reduced 97.01%	224 $7,000
Q1 2020 May 12, 2020	SELL	$19.54 - $38.85 $17,234 - $34,265	-882 Reduced 10.54%	7,490 $224,000
Q4 2019 Feb 11, 2020	SELL	$17.95 - $29.41 $4,810 - $7,881	-268 Reduced 3.1%	8,372 $231,000
Q2 2019 Aug 08, 2019	BUY	$9.78 - $24.52 $84,499 - $211,852	8,640 New	8,640 $0

Others Institutions Holding IOVA

# of Institutions

313

Shares Held

241M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Iovance Biotherapeutics, Inc. Transaction History